AstraZeneca Pharma India Limited — Others, 10-02-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

AstraZeneca Pharma India Limited has announced a board meeting focused on ensuring compliance with SEBI regulations regarding the dematerialization of securities. The company received a confirmation certificate from its Registrar and Transfer Agent, Integrated Registry Management Services, indicating compliance for the period from January 1 to January 31, 2025. This update reflects AstraZeneca's commitment to regulatory adherence and operational efficiency. Investors may view this as a positive outlook, as compliance with such regulations enhances the company's governance and reliability, potentially fostering greater investor confidence.